Centennial Surgical Suture Inc Stock Price Today (NSE: CSURGSU)
Fundamental Score
Centennial Surgical Suture Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Centennial Surgical Suture Inc share price today is ₹76.27, down 1.91% on NSE/BSE as of 30 March 2026. Centennial Surgical Suture Inc (CSURGSU) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹38.05 (Cr). The 52-week high for CSURGSU share price is ₹189.00 and the 52-week low is ₹77.00. The company has a Return on Equity (ROE) of -4.64% and a debt-to-equity ratio of 0.35.
Centennial Surgical Suture Inc Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Centennial Surgical Suture Inc Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Centennial Surgical Suture Inc Share Price: A Financial Stability Analysis
The medical equipment and supplies industry is currently experiencing a period of increased scrutiny regarding pricing and supply chain resilience. This evolving landscape presents both opportunities and challenges for companies operating within it. This analysis examines the financial stability of Centennial Surgical Suture Inc, focusing on key metrics influencing its long-term viability. Specifically, we will observe factors impacting the Centennial Surgical Suture Inc share price, currently trading at ₹86.5. This analysis is a component of an 80-parameter fundamental audit, rigorously verified by Sweta Mishra, ensuring a comprehensive perspective.
A significant concern is the absence of a Price-to-Earnings (PE) ratio for Centennial Surgical Suture Inc. This lack of a PE ratio can indicate that the company is not currently profitable or is experiencing significant earnings volatility. Further investigation into the underlying reasons for the missing PE is warranted. Compared to its sector peers, the lack of positive earnings sets Centennial Surgical Suture Inc apart. While
Choksi Asia and other competitors might be facing similar industry headwinds, understanding the comparative effectiveness of Centennial’s management in navigating these challenges is crucial for investors.The Return on Capital Employed (ROCE) of 3.94% is another key area of focus. ROCE measures how effectively a company is using its capital to generate profits. A ROCE of 3.94% suggests a relatively low return on invested capital. This low return directly impacts the company's ability to build and maintain a strong economic moat, potentially hindering its competitive advantage and future growth prospects. This also affects the ability to reinvest earnings for expansion or research and development. For instance, if Centennial Surgical Suture Inc is compared to peers such as OSEL DEVICES LIMITED and Transpact Enterprises Ltd, the relatively low ROCE suggests that Centennial might not be as efficient in capital allocation.
In conclusion, the Centennial Surgical Suture Inc share price and financial stability assessment reveal areas requiring further scrutiny. The absence of a PE ratio coupled with a 3.94% ROCE raise questions about profitability and capital efficiency. The analysis presented here is based on publicly available information and serves to highlight potential areas of concern for investors. It is observational and does not constitute financial advice or a recommendation to buy or sell shares of Centennial Surgical Suture Inc. A thorough investigation of these factors is crucial for making informed investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Centennial Surgical Suture Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CSURGSU across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-4.64%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.94%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-107.69%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-5.68%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-0.77% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (0.35x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Centennial Surgical Suture Inc Financial Statements
Comprehensive financial data for Centennial Surgical Suture Inc including income statement, balance sheet and cash flow
About CSURGSU (Centennial Surgical Suture Inc)
Centennial Surgical Suture Inc. (CSURGSU) is a global provider of premium surgical suture and advanced wound closure solutions for the modern operating room. The company distinguis...hes itself through a commitment to innovation, developing a comprehensive portfolio of products designed to meet the diverse needs of surgeons across various specialties. CSURGSU blends traditional craftsmanship with cutting-edge technology to create sutures that offer superior tensile strength, smooth passage through tissue, and optimal knot security. Their offerings span the spectrum of suture materials, from rapidly absorbable options ideal for delicate tissue repair to robust non-absorbable sutures designed for long-term support. CSURGSU strives to be a trusted partner for surgeons, improving patient outcomes and advancing surgical techniques. CSURGSU's extensive product catalog encompasses a wide range of absorbable and non-absorbable sutures, each engineered for specific surgical applications. Absorbable sutures are crafted with varying absorption profiles, providing surgeons with the flexibility to choose the ideal material for tissue healing rates. The non-absorbable suture line offers permanent support and is available in a variety of materials, including braided polymers, monofilaments, and specialized metal options. Beyond sutures, CSURGSU provides a suite of complementary wound closure devices, including surgical meshes, surgical staplers, and tissue adhesives. These devices complement their suture lines and enables surgeons to create effective and efficient wound closures. Underpinning CSURGSU's product innovation is a dedication to quality and regulatory compliance. The company operates state-of-the-art manufacturing facilities that adhere to the highest international standards. Rigorous quality control procedures are implemented throughout the entire manufacturing process, from raw material sourcing to final product packaging. This ensures that every CSURGSU suture meets or exceeds the expectations of surgeons and regulatory bodies. Moreover, CSURGSU fosters a culture of continuous improvement, constantly seeking opportunities to enhance its products, processes, and customer service. This commitment to excellence has established CSURGSU as a reliable and respected name in surgical suture technology.
Company Details
Key Leadership
CSURGSU Share Price: Frequently Asked Questions
What is the current share price of Centennial Surgical Suture Inc (CSURGSU)?
As of 30 Mar 2026, 12:07 pm IST, Centennial Surgical Suture Inc share price is ₹76.27. The CSURGSU stock has a market capitalisation of ₹38.05 (Cr) on NSE/BSE.
Is CSURGSU share price Overvalued or Undervalued?
CSURGSU share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 47.87x. Based on this relative valuation, the Centennial Surgical Suture Inc stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of CSURGSU share price?
The 52-week high of CSURGSU share price is ₹189.00 and the 52-week low is ₹77.00. These values are updated daily from NSE/BSE price data.
What factors affect the Centennial Surgical Suture Inc share price?
Key factors influencing CSURGSU share price include quarterly earnings growth (Sales Growth: -5.68%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Centennial Surgical Suture Inc a good stock for long-term investment?
Centennial Surgical Suture Inc shows a 5-year Profit Growth of N/A% and an ROE of -4.64%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.35 before investing in CSURGSU shares.
How does Centennial Surgical Suture Inc compare with its industry peers?
Centennial Surgical Suture Inc competes with major peers in the Medical Equipment & Supplies. Investors should compare CSURGSU share price P/E of 0.00x and ROE of -4.64% against the industry averages to determine competitive standing.
What is the P/E ratio of CSURGSU and what does it mean?
CSURGSU share price has a P/E ratio of N/Ax compared to the industry average of 47.87x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is CSURGSU performing according to Bull Run's analysis?
CSURGSU has a Bull Run fundamental score of 13.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does CSURGSU belong to?
CSURGSU operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Centennial Surgical Suture Inc share price.
What is Return on Equity (ROE) and why is it important for CSURGSU?
CSURGSU has an ROE of -4.64%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Centennial Surgical Suture Inc generates profits from shareholders capital.
How is CSURGSU debt-to-equity ratio and what does it indicate?
CSURGSU has a debt-to-equity ratio of 0.35, which indicates moderate leverage that should be monitored.
What is CSURGSU dividend yield and is it a good dividend stock?
CSURGSU offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Centennial Surgical Suture Inc shares.
How has CSURGSU share price grown over the past 5 years?
CSURGSU has achieved 5-year growth rates of: Sales Growth -0.77%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in CSURGSU and why does it matter?
Promoters hold 46.89% of CSURGSU shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Centennial Surgical Suture Inc.
What is CSURGSU market capitalisation category?
CSURGSU has a market capitalisation of ₹38 crores, placing it in the Small-cap category.
How volatile is CSURGSU stock?
CSURGSU has a beta of N/A. A beta > 1 suggests the Centennial Surgical Suture Inc stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is CSURGSU operating profit margin trend?
CSURGSU has a 5-year average Operating Profit Margin (OPM) of 10.71%, indicating the company's operational efficiency.
How is CSURGSU quarterly performance?
Recent quarterly performance shows Centennial Surgical Suture Inc YoY Sales Growth of -5.68% and YoY Profit Growth of -107.69%.
What is the institutional holding pattern in CSURGSU?
CSURGSU has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Centennial Surgical Suture Inc stock.